Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomaras

Showing results (321-330 of 525) with videos related to

Pageof 53
Sort By:
Plos One|March 12, 2014
IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteriaKwan-Ki Hwang, Ashley M Trama, Daniel M Kozink, et al.
Plos Pathogens|June 27, 2020
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II TrialYves Lévy, Christine Lacabaratz, Kim Ellefsen-Lavoie, et al.
The Journal of Clinical Investigation|August 28, 2012
CD4 T follicular helper cell dynamics during SIV infectionConstantinos Petrovas, Takuya Yamamoto, Michael Y Gerner, et al.
The Journal of Clinical Investigation|April 3, 2025
Safety and implementation of phase I randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newbornsAvy Violari, Kennedy Otwombe, William Hahn, et al.
Journal of Virology|February 2, 2018
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among VaccineesNicole L Yates, Allan C deCamp, Bette T Korber, et al.
Frontiers in Immunology|May 29, 2025
Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccinesCassie G Ackerley, Srilatha Edupuganti, Chenchen Yu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2022
Safety and Pharmacokinetics of Intravenous 10-1074 and VRC01LS in Young ChildrenEdmund V Capparelli, Gbolahan Ajibola, Kenneth Maswabi, et al.
Molecular Systems Biology|May 4, 2019
Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protectionSrivamshi Pittala, Kenneth Bagley, Jennifer A Schwartz, et al.
Journal of Virology|October 19, 2007
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infectionS Munir Alam, Richard M Scearce, Robert J Parks, et al.
Journal of Virology|March 4, 2016
Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast MilkCody S Nelson, Justin Pollara, Erika L Kunz, et al.
Pageof 53

Showing results (321-330 of 525) with videos related to

Sort By:
Pageof 53
Plos One|March 12, 2014
IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteriaKwan-Ki Hwang, Ashley M Trama, Daniel M Kozink, et al.
Plos Pathogens|June 27, 2020
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II TrialYves Lévy, Christine Lacabaratz, Kim Ellefsen-Lavoie, et al.
The Journal of Clinical Investigation|August 28, 2012
CD4 T follicular helper cell dynamics during SIV infectionConstantinos Petrovas, Takuya Yamamoto, Michael Y Gerner, et al.
The Journal of Clinical Investigation|April 3, 2025
Safety and implementation of phase I randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newbornsAvy Violari, Kennedy Otwombe, William Hahn, et al.
Journal of Virology|February 2, 2018
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among VaccineesNicole L Yates, Allan C deCamp, Bette T Korber, et al.
Frontiers in Immunology|May 29, 2025
Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccinesCassie G Ackerley, Srilatha Edupuganti, Chenchen Yu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2022
Safety and Pharmacokinetics of Intravenous 10-1074 and VRC01LS in Young ChildrenEdmund V Capparelli, Gbolahan Ajibola, Kenneth Maswabi, et al.
Molecular Systems Biology|May 4, 2019
Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protectionSrivamshi Pittala, Kenneth Bagley, Jennifer A Schwartz, et al.
Journal of Virology|October 19, 2007
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infectionS Munir Alam, Richard M Scearce, Robert J Parks, et al.
Journal of Virology|March 4, 2016
Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast MilkCody S Nelson, Justin Pollara, Erika L Kunz, et al.
Pageof 53